With a corrected QT interval of 492 ms in a patient taking domperidone, should domperidone be discontinued?

Yes, discontinue domperidone immediately with a QTc of 492 ms

With a QTc of 492 ms in a patient currently taking domperidone, you should hold the medication immediately. This QTc value approaches the critical threshold where risk of torsades de pointes (TdP) significantly increases, and domperidone is a known QT-prolonging antiemetic that can cause life-threatening arrhythmias 1.

Why This Decision is Critical

The 2023 Canadian Cardiovascular Society guidelines clearly state that increased risk for TdP occurs when the QTc exceeds 500 ms 1. Your patient at 492 ms is dangerously close to this threshold—only 8 ms away from the high-risk zone. The guidelines emphasize that antiemetics (including domperidone) are among the "anti's" that commonly cause acquired long QT syndrome (aLQTS) 1.

Immediate Actions Required

1. Stop domperidone now - Do not wait for further prolongation
2. Check electrolytes immediately - Correct any hypokalemia, hypomagnesemia, or hypocalcemia 1
3. Review all other medications - Identify and eliminate any additional QT-prolonging drugs the patient may be taking 1
4. Assess renal function - Many QT-prolonging drugs accumulate with renal impairment 1
5. Repeat ECG after discontinuation - Monitor for QTc normalization after stopping the offending agent 1

Risk Factors to Consider

Your patient may have additional risk factors that compound the danger:

• Female sex - Women are at significantly higher risk for drug-induced TdP 1
• Elderly age - Increases arrhythmia risk 1
• Underlying heart disease - Structural cardiac abnormalities elevate risk 1
• Concurrent QT-prolonging medications - Research shows 69.7% of domperidone patients are coprescribed other QT-interacting drugs 2

Evidence on Domperidone's Cardiac Risk

While one recent study suggested domperidone at conventional doses (30-80 mg/day) caused clinically significant QTc prolongation in only 6% of patients 3, this is misleading for your situation. Your patient already has a prolonged QTc of 492 ms while on the drug. The 2023 guidelines make clear that avoidance of QT-prolonging medications is critical—data show cardiac arrest/sudden death rates of 27.5% in non-compliant QT-prolonging drug users versus 0.6% in compliant non-users 1.

Alternative Antiemetic Options

The guidelines specifically note that low-risk antiemetic alternatives exist, including aprepitant and dexamethasone 1. Consider these safer options for symptom management rather than continuing a drug that has already caused significant QTc prolongation.

Common Pitfall to Avoid

Do not simply "monitor" the QTc while continuing domperidone. The American Heart Association states that when ECG signs of impending TdP develop, the recommended action is to discontinue the offending drug 4. The guidelines emphasize it is "often preferable to consider an alternate drug that does not affect the QTc...rather than just monitoring the ECG" 1.

Expected Outcome

In most cases of aLQTS, the QT interval normalizes after discontinuation of the offending agent 1. Repeat the ECG in 2-3 days after stopping domperidone. If the QTc does not normalize after removal of the drug and correction of electrolyte abnormalities, consider underlying congenital long QT syndrome 1.